Showing results (531-540 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|March 2, 2018
Use of next-generation sequencing in the CHAT study (acute HCV in HIV): effect of baseline resistance-associated NS3 variants on treatment failureGurmit Kaur Jagjit Singh, Steve Kaye, James C Abbott, et al.HIV Clinical Trials|March 2, 2018
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA CohortAntonella d'Arminio Monforte, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.HIV Clinical Trials|December 14, 2001
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant womenE P Acosta, C Zorrilla, R Van Dyke, et al.HIV Clinical Trials|December 14, 2001
Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patientsA Casado, E Consiglio, D Podzamczer, et al.HIV Clinical Trials|January 31, 2002
Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis studyDonato Torre, Roberto TambiniHIV Clinical Trials|January 31, 2002
Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliterCarmen de Mendoza, José Tomás Ramos, Luis Ciria, et al.HIV Clinical Trials|January 31, 2002
Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimensNatasha Press, Gil Kimel, Marianne Harris, et al.HIV Clinical Trials|August 21, 2002
The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinationsAlain Lafeuillade, Gilles Hittinger, Stéphane Chadapaud, et al.HIV Clinical Trials|August 21, 2002
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCVMassimo Puoti, Barbara Zanini, Raffaele Bruno, et al.HIV Clinical Trials|May 29, 2002
Incorporating quality of life measures in HIV clinical trialsMaria K Lin, Albert W Wu, Dennis A RevickiPageof 68